Bronchiolitis Obliterans Clinical Trials

64 clinical trials for Bronchiolitis Obliterans across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans — RECRUITING · NA
• TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients — RECRUITING
• BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) — RECRUITING · PHASE2
• Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome — RECRUITING
• Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Transplantation — COMPLETED · NA
• Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant — TERMINATED · PHASE2
• Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) — TERMINATED · PHASE3
• Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) — COMPLETED · PHASE3
• Prospective Evaluations of Infectious Complication in Lung Transplant Recipients — COMPLETED
• TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS — ACTIVE_NOT_RECRUITING
• Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant — TERMINATED · PHASE1
• Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) — COMPLETED · PHASE3
• Hp129 Xenon Imaging and BOS in Lung Transplantation — COMPLETED · PHASE1
• Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation — TERMINATED · PHASE3
• High Intensity Intervallic Training in Children With Bronchiolitis Obliterans — COMPLETED · NA
• Measures of Respiratory Health (MRH) — OTHER
• Microparticles and Bronchiolitis Obliterans Syndrome — COMPLETED
• Evaluating Bronchodilator Response in Patients With Bronchiectasis — OTHER · NA
• Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients — COMPLETED · PHASE1
• The Safety and Tolerability of Pirfenidone for BOS After HCT — COMPLETED · PHASE1
• A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation — COMPLETED · PHASE1
• INSPIRE Continuation Post-Approval Study — COMPLETED
• Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans — COMPLETED · PHASE4
• Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant — TERMINATED · PHASE2
• Mesenchymal Stem Cell Therapy for Lung Rejection — COMPLETED · PHASE1
• Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome — COMPLETED · PHASE2
• Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans — COMPLETED · PHASE2
• Viral Triggers in Pediatric Lung Transplantation — COMPLETED
• Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3 — WITHDRAWN · NA
• Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells. — COMPLETED · NA
• A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD — TERMINATED · PHASE2
• Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC — OTHER
• Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantation — COMPLETED · NA
• Immune Mechanisms of Rejection in Human Lung Allografts — COMPLETED
• Montelukast to Treat Bronchiolitis Obliterans — COMPLETED · PHASE2
• Prospective Study for Transplant Optimization Using Functional Imaging (TROFI) — TERMINATED · PHASE2
• Targeted Therapy of Bronchiolitis Obliterans Syndrome — COMPLETED · PHASE2
• MSC for Treatment of Interstitial Lung Disease After Allo-HSCT — OTHER · PHASE1
• Transplant Optimization Using Functional Imaging (TROFI) — COMPLETED · NA
• Transplant Optimization Using Functional Imaging — COMPLETED · NA
• Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation — COMPLETED
• Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO — OTHER
• Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant — COMPLETED · PHASE2
• Vitamin D in Bronchiolitis Obliterans Syndrome — COMPLETED · PHASE4
• LCI and Bronchial Inflammation in Patients With BO — COMPLETED
• L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients — TERMINATED · PHASE2
• Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) — TERMINATED · PHASE3
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation — COMPLETED · PHASE1
• Montelukast in Bronchiolitis Obliterans Syndrome — COMPLETED · PHASE4

Refine this search